Andrew N Nicolaides Selected Research

Andrew N Nicolaides Research Topics

Disease

12	Stroke (Strokes) 11/2022 - 07/2005
8	Carotid Stenosis (Carotid Artery Stenosis) 11/2023 - 07/2005
6	Transient Ischemic Attack 07/2022 - 12/2010
6	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021 - 01/2002
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 05/2009
4	Hemorrhage 04/2022 - 09/2016
4	Pathologic Constriction (Stenosis) 04/2014 - 07/2005
4	Edema (Dropsy) 07/2003 - 11/2002
3	Pain (Aches) 01/2020 - 07/2003
3	Atherosclerotic Plaque (Atheroma) 10/2013 - 03/2007
2	Brain Infarction 04/2022 - 01/2022
2	Hypertension (High Blood Pressure) 01/2020 - 03/2003
2	Acute Coronary Syndrome 11/2013 - 01/2002
1	Carotid Artery Diseases 07/2022
1	Myocardial Infarction 07/2022
1	Infarction (Infarctions) 05/2021
1	Cellulitis 11/2020
1	Inflammation (Inflammations) 04/2020
1	Disease Progression 01/2020
1	Leg Ulcer 01/2020
1	Hematoma 01/2020
1	Ischemic Stroke 04/2014
1	Venous Thromboembolism 10/2013
1	Amaurosis Fugax 05/2011
1	Coronary Disease (Coronary Heart Disease) 06/2010
1	Coronary Artery Disease (Coronary Atherosclerosis) 06/2010
1	Insulin Resistance 07/2005
1	Restless Legs Syndrome (Restless Legs) 07/2003
1	Chronic Disease (Chronic Diseases) 07/2003
1	Paresthesia (Dysesthesia) 07/2003
1	Varicose Veins (Varicose Vein) 11/2002
1	Thrombophlebitis 11/2002
1	Thrombosis (Thrombus) 01/2002
1	Thrombocytopenia (Thrombopenia) 01/2002

Drug/Important Bio-Agent (IBA)

4	LipidsIBA 07/2022 - 04/2014
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2002 - 01/2002
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2022 - 10/2013
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 04/2020 - 02/2018
2	FlavonoidsIBA 01/2020 - 07/2003
2	AnticoagulantsIBA 09/2016 - 11/2002
2	Retinaldehyde (Retinal)IBA 04/2014 - 12/2010
2	CreatinineIBA 04/2014 - 12/2010
2	Phospholipases (Phospholipase)IBA 11/2013 - 06/2010
1	Fibric Acids (Fibrates)IBA 07/2022
1	oxidized low density lipoproteinIBA 07/2022
1	Ezetimibe (Zetia)FDA Link 07/2022
1	PCSK9 InhibitorsIBA 07/2022
1	LDL CholesterolIBA 07/2022
1	Pentoxifylline (Trental)FDA LinkGeneric 01/2020
1	glucuronyl glucosamine glycan sulfate (sulodexide)IBA 01/2020
1	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 07/2014
1	Secretory Phospholipases A2IBA 11/2013
1	IsoenzymesIBA 11/2013
1	Matrix Metalloproteinases (MMPs)IBA 10/2013
1	N 30IBA 05/2011
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 06/2010
1	Biomarkers (Surrogate Marker)IBA 06/2010
1	Lipoproteins (Lipoprotein)IBA 06/2010
1	Indicators and Reagents (Reagents)IBA 05/2009
1	MetallothioneinIBA 03/2007
1	CholesterolIBA 07/2005
1	C-Reactive ProteinIBA 07/2005
1	HesperidinIBA 07/2003
1	Diosmin (Daflon)IBA 07/2003
1	Antihypertensive Agents (Antihypertensives)IBA 03/2003
1	troxerutinIBA 01/2003
1	Heparin (Liquaemin)FDA LinkGeneric 01/2002
1	argatroban (MPQA)FDA Link 01/2002
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2002
1	AntithrombinsIBA 01/2002
1	HirudinsIBA 01/2002

Therapy/Procedure

10	Carotid Endarterectomy 11/2023 - 07/2005
7	Therapeutics 01/2023 - 04/2014
4	Vascular Surgical Procedures 11/2022 - 01/2021
3	Compression Stockings 10/2006 - 11/2002
1	Sclerotherapy 01/2020
1	Drug Therapy (Chemotherapy) 01/2020
1	Conservative Treatment 01/2020
1	Endarterectomy (Thromboendarterectomy) 10/2010
1	Ligation 11/2002